1. Home
  2. LPG vs ALMR Comparison

LPG vs ALMR Comparison

Compare LPG & ALMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dorian LPG Ltd.

LPG

Dorian LPG Ltd.

HOLD

Current Price

$43.77

Market Cap

1.8B

ML Signal

HOLD

Logo Alamar Biosciences Inc. Common Stock

ALMR

Alamar Biosciences Inc. Common Stock

N/A

Current Price

$27.43

Market Cap

1.5B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
LPG
ALMR
Founded
2013
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2014
2026

Fundamental Metrics

Financial Performance
Metric
LPG
ALMR
Price
$43.77
$27.43
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$39.33
N/A
AVG Volume (30 Days)
605.2K
198.3K
Earning Date
05-21-2026
N/A
Dividend Yield
8.26%
N/A
EPS Growth
112.15
N/A
EPS
4.54
N/A
Revenue
$481,511,242.00
N/A
Revenue This Year
$35.73
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.12
N/A
Revenue Growth
36.27
N/A
52 Week Low
$23.76
$21.58
52 Week High
$48.12
$29.43

Technical Indicators

Market Signals
Indicator
LPG
ALMR
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
LPG
ALMR

About LPG Dorian LPG Ltd.

Dorian LPG Ltd is an international liquefied petroleum gas shipping company focused on owning and operating gas carriers, or VLGCs. The company currently owns and operates around 22 modern VLGCs, including nineteen new fuel-efficient 84,000 cbm ECO-design VLGCs. Dorian LPG has offices in Connecticut, USA, London, United Kingdom, and Athens, Greece. IT operates in one reportable segment, the international transportation of LPG.

About ALMR Alamar Biosciences Inc. Common Stock

Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.

Share on Social Networks: